Susquehanna International Group
NVAX icon

Susquehanna International Group’s Novavax NVAX Stock Holding History

Susquehanna International Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.9M Sell
847,400
-126,800
-13% -$1.15M ﹤0.01% 3696
2025
Q4 		$6.55M Sell
974,200
-340,400
-26% -$2.57M ﹤0.01% 3621
2025
Q3 		$11.4M Sell
1,314,600
-181,100
-12% -$1.41M ﹤0.01% 2878
2025
Q2 		$9.42M Buy
1,495,700
+241,700
+19% +$1.6M ﹤0.01% 2914
2025
Q1 		$8.04M Buy
1,254,000
+257,500
+26% +$2.13M ﹤0.01% 2829
2024
Q4 		$8.01M Sell
996,500
-292,400
-23% -$2.82M ﹤0.01% 2934
2024
Q3 		$16.3M Sell
1,288,900
-176,600
-12% -$2.28M ﹤0.01% 2042
2024
Q2 		$18.6M Buy
1,465,500
+554,500
+61% +$5.58M ﹤0.01% 1808
2024
Q1 		$4.35M Sell
911,000
-462,800
-34% -$2.15M ﹤0.01% 3861
2023
Q4 		$6.59M Sell
1,373,800
-786,600
-36% -$4.82M ﹤0.01% 3257
2023
Q3 		$15.6M Buy
2,160,400
+153,700
+8% +$1.23M ﹤0.01% 2035
2023
Q2 		$14.9M Buy
2,006,700
+608,400
+44% +$4.78M ﹤0.01% 2033
2023
Q1 		$9.69M Sell
1,398,300
-824,900
-37% -$7.59M ﹤0.01% 2500
2022
Q4 		$22.9M Buy
2,223,200
+1,312,800
+144% +$23.2M 0.01% 1409
2022
Q3 		$16.6M Sell
910,400
-570,600
-39% -$24.7M ﹤0.01% 1596
2022
Q2 		$76.2M Sell
1,481,000
-871,100
-37% -$45.1M 0.02% 632
2022
Q1 		$173M Sell
2,352,100
-944,500
-29% -$84.2M 0.03% 442
2021
Q4 		$472M Buy
3,296,600
+1,142,500
+53% +$196M 0.07% 216
2021
Q3 		$447M Buy
2,154,100
+762,100
+55% +$168M 0.06% 270
2021
Q2 		$296M Buy
1,392,000
+48,500
+4% +$8.89M 0.04% 367
2021
Q1 		$244M Sell
1,343,500
-881,100
-40% -$176M 0.04% 385
2020
Q4 		$248M Buy
2,224,600
+742,800
+50% +$79M 0.04% 363
2020
Q3 		$161M Buy
1,481,800
+398,800
+37% +$48.6M 0.03% 404
2020
Q2 		$90.3M Buy
1,083,000
+584,600
+117% +$22.4M 0.02% 548
2020
Q1 		$6.77M Sell
498,400
-215,800
-30% -$1.83M ﹤0.01% 2194
2019
Q4 		$2.84M Buy
714,200
+272,000
+62% +$1.18M ﹤0.01% 3784
2019
Q3 		$2.22M Sell
442,200
-156,200
-26% -$855K ﹤0.01% 3988
2019
Q2 		$3.51M Buy
598,400
+545,510
+1,031% +$4.29M ﹤0.01% 3219
2019
Q1 		$583K Buy
52,890
+22,575
+74% +$713K ﹤0.01% 5991
2018
Q4 		$1.12M Buy
30,315
+9,055
+43% +$351K ﹤0.01% 4471
2018
Q3 		$799K Sell
21,260
-7,390
-26% -$208K ﹤0.01% 5667
2018
Q2 		$768K Sell
28,650
-12,205
-30% -$413K ﹤0.01% 5931
2018
Q1 		$1.72M Buy
40,855
+30,705
+303% +$1.23M ﹤0.01% 4211
2017
Q4 		$252K Sell
10,150
-975
-9% -$23.8K ﹤0.01% 7877
2017
Q3 		$254K Sell
11,125
-5,740
-34% -$129K ﹤0.01% 7662
2017
Q2 		$388K Sell
16,865
-1,990
-11% -$39K ﹤0.01% 7111
2017
Q1 		$483K Sell
18,855
-5,070
-21% -$139K ﹤0.01% 6550
2016
Q4 		$603K Sell
23,925
-31,030
-56% -$905K ﹤0.01% 6593
2016
Q3 		$2.29M Buy
54,955
+38,080
+226% +$4.92M ﹤0.01% 3334
2016
Q2 		$2.45M Sell
16,875
-11,555
-41% -$1.32M ﹤0.01% 3233
2016
Q1 		$2.93M Buy
28,430
+8,335
+41% +$894K ﹤0.01% 3087
2015
Q4 		$3.37M Sell
20,095
-2,285
-10% -$352K ﹤0.01% 3083
2015
Q3 		$3.17M Sell
22,380
-27,710
-55% -$6.21M ﹤0.01% 3404
2015
Q2 		$11.2M Buy
50,090
+7,085
+16% +$1.25M ﹤0.01% 1878
2015
Q1 		$7.11M Buy
43,005
+32,895
+325% +$5.34M ﹤0.01% 2258
2014
Q4 		$1.2M Sell
10,110
-13,105
-56% -$1.37M ﹤0.01% 5497
2014
Q3 		$1.94M Buy
23,215
+910
+4% +$82.2K ﹤0.01% 4668
2014
Q2 		$2.06M Sell
22,305
-110
-0.5% -$9.67K ﹤0.01% 4596
2014
Q1 		$2.03M Sell
22,415
-6,625
-23% -$740K ﹤0.01% 4333
2013
Q4 		$2.97M Buy
29,040
+12,540
+76% +$886K ﹤0.01% 3674
2013
Q3 		$1.04M Buy
16,500
+11,685
+243% +$658K ﹤0.01% 5198
2013
Q2 		$197K Buy
+4,815
New +$209K ﹤0.01% 7446

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's NVAX Position: Q1 2026 in Review

Susquehanna International Group increased its Novavax (NVAX) stake by 93% in Q1 2026, buying an estimated $3.66M and bringing the position to 834,842 shares worth $6.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3719.

Susquehanna International Group first reported a position in NVAX in Q3 2013 and has held it in 48 quarters since. The position peaked at $284M in Q3 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Susquehanna International Group held 834,842 shares of Novavax worth $6.8M as of Q1 2026.
  • Susquehanna International Group bought 403,223 Novavax shares in Q1 2026, an estimated $3.66M.
  • Novavax made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3719 holding.
  • Susquehanna International Group first reported a position in Novavax in Q3 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Novavax position peaked at $284M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.